|
Anemia in the News
Anemia affects body ... and maybe the mind
Study among elderly women shows seniors especially may be at risk
For older adults, anemia's trademark loss of oxygen-toting red blood cells has long been linked to fatigue, muscle weakness and other physical ailments. Now
researchers at Johns Hopkins have found a relationship between anemia and impaired thinking, too.
"Our work supports the notion that mild anemia may be an independent risk factor for so-called executive-function impairment in older adults," says Paulo
Chaves, M.D., P.h.D., an assistant professor at The Johns Hopkins University School of Medicine and the lead author of the study. "If further studies confirm that's true, this could mean that
correction of anemia in these patients might offer a chance to prevent such a cognitive decline."
Reporting on the research in the September issue of The Journal of the American Geriatrics Society, the Hopkins investigators went looking for such an effect because
previous studies showed that age-related declines in the brain's so-called executive function - problem solving, planning, assessing dangers, following up on important activities - lead to declines
in self-sufficiency.
"Executive function impairment, which happens often before memory loss occurs, may happen early on in the process of becoming unable to carry on with instrumental
day-to-day living activities, such as shopping, cooking, taking medications, paying bills, walking, etc.," says Chaves.
Chaves and his team gave three psychological tests commonly used to evaluate executive function to 364 women, all between 70 and 80 years old, who were living in
Baltimore, Md. Approximately 10 percent had anemia, which was of mild intensity.
Some 15 percent of those with the worst results on all three of the tests were anemic, compared to only 3 percent who scored best. Those with anemia were four to five
times more likely to perform worst on the executive function tests, compared to those with normal blood hemoglobin, after taking into account the effect of other factors that affect cognition, such as
age, education and existing diseases.
"These preliminary results don't prove that anemia causes impaired executive function, nor indicate that treatment of anemia would necessarily lead to better
executive function," says Chaves. "However, they are compelling enough to serve as a roadmap for continued research."
How anemia could affect thinking remains to be determined. It could be because it chronically diminishes the supply of oxygen to the brain. Another view proposes that the
fatigue accompanying anemia leads to inactivity and the loss of aerobic-fitness benefits to the prefrontal cortex.
REVLIMID® Approved for Treatment of Deletion 5q Myelodysplastic Syndromes in Japan - PharmiWeb
... dexamethasone is indicated for the treatment of multiple myeloma patients who have received at least one prior therapy. REVLIMID (lenalidomide) is indicated for patients with transfusion-dependent anemia due to ...
Risk factors and correlates for anemia in HIV treatment-naive infected patients: a cross ... - BioMed Central
Hematologic manifestations of the human immunodeficiency virus (HIV) infection are a well-recognized complication of the disease and may be clinically important. Our objective was to determine the risk factors for ...
Celgene Officially Notified of ANDA Filing for REVLIMID(R) - Forbes
... dexamethasone is indicated for the treatment of multiple myeloma patients who have received at least one prior therapy. REVLIMID(R) (lenalidomide) is indicated for patients with transfusion-dependent anemia due ...
Medical marijuana as cancer treatment - San Gabriel Valley Tribune
Then my doctor prescribed This medication has quinine and is usually used for the treatment of malaria. Now I take one every ... The possible consequences are anemia and neurological problems. Dr. Lisa Sanders ...
New research showing uses for medical marijuana - Chicago Tribune
This medication has quinine and is usually used for the treatment of malaria . Now I take one every other night ... The possible consequences are anemia and neurological problems. Lisa Sanders, M.D., described a case ...
Novartis drug Tasigna(R) approved in Switzerland after fast-track review for treatment of ... - TradingMarkets.com
Treatment with Tasigna has been associated with hematological side effects such as thrombocytopenia, neutropenia and anemia which was generally reversible and usually managed by withholding Tasigna temporarily or ...
FDA clears path for ProMetic’s anemia drug - Stockhouse
It therefore provides great promise of serving as a stand-alone therapeutic in the treatment of patients with anemia. PBI-1402 is an affordable low molecular weight synthetic candidate drug, relative to costly ...
Analysis: Amgen, holding billions overseas, looks for deals - Reuters
which 30 years ago developed blockbuster anemia drug Epogen and in June launched ... Genome has filed for regulatory approval of a drug that could become the first new treatment for lupus in more than 50 years,
Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 ... - Earthtimes
... granted marketing authorisation for VPRIV(R) (velaglucerase alfa), a human cell line derived enzyme replacement therapy (ERT) for the long-term treatment of ... clinically significant anemia and thrombocytopenia.
PRINCETON: Culbreath back on the football field - Packet Online
Aplastic anemia was causing his immune system to attack his bone marrow. Not long after diagnosis, he began intravenous drug treatment. ”They suppressed my immune system and allowed my bone marrow to recover,” he ...
|
|
